NCT02661061 Ketamine for Relapse Prevention in Recurrent Depressive Disorder Status TERMINATED Phase PHASE1
NCT02659787 Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology Status COMPLETED Phase NA
NCT02658617 Functional Neuroanatomy and Regional Metabolism Before and After Treatment With Duloxetine Status COMPLETED Phase N/A
NCT02657317 Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans Status COMPLETED Phase NA
NCT02655354 A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Status COMPLETED Phase NA
NCT02652832 Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels Status UNKNOWN Phase NA
NCT02650544 Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression Status UNKNOWN Phase PHASE2
NCT02648022 Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment Status COMPLETED Phase NA
NCT02634697 Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02623231 The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients Status UNKNOWN Phase PHASE2/PHASE3